Manufacturers Life Insurance Company, The Supernus Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $100 Billion
- Q1 2025
A detailed history of Manufacturers Life Insurance Company, The transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 25,909 shares of SUPN stock, worth $807,324. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,909
Previous 25,241
2.65%
Holding current value
$807,324
Previous $912,000
7.02%
% of portfolio
0.0%
Previous 0.0%
Shares
35 transactions
Others Institutions Holding SUPN
# of Institutions
305Shares Held
60.8MCall Options Held
8.8KPut Options Held
6.3K-
Black Rock Inc. New York, NY10.4MShares$324 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.16MShares$192 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.2MShares$162 Million2.59% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.9MShares$90.5 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.7MShares$84.1 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.67B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...